DK3515478T3 - Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf - Google Patents

Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf Download PDF

Info

Publication number
DK3515478T3
DK3515478T3 DK17853889.8T DK17853889T DK3515478T3 DK 3515478 T3 DK3515478 T3 DK 3515478T3 DK 17853889 T DK17853889 T DK 17853889T DK 3515478 T3 DK3515478 T3 DK 3515478T3
Authority
DK
Denmark
Prior art keywords
siglec
antibodies
methods
Prior art date
Application number
DK17853889.8T
Other languages
Danish (da)
English (en)
Inventor
Linda Liu
Dallas Benjamin Flies
Solomon Langermann
Original Assignee
Nextcure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nextcure Inc filed Critical Nextcure Inc
Application granted granted Critical
Publication of DK3515478T3 publication Critical patent/DK3515478T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A61K39/001111—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74—Inducing cell proliferation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
DK17853889.8T 2016-09-21 2017-09-21 Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf DK3515478T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662397794P 2016-09-21 2016-09-21
US201762451271P 2017-01-27 2017-01-27
US201762500578P 2017-05-03 2017-05-03
PCT/US2017/052714 WO2018057735A1 (en) 2016-09-21 2017-09-21 Antibodies for siglec-15 and methods of use thereof

Publications (1)

Publication Number Publication Date
DK3515478T3 true DK3515478T3 (da) 2024-05-21

Family

ID=65352347

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17853889.8T DK3515478T3 (da) 2016-09-21 2017-09-21 Antistoffer til SIGLEC-15 og fremgangsmåder til anvendelse deraf

Country Status (12)

Country Link
US (1) US11390675B2 (enExample)
EP (1) EP3515478B1 (enExample)
JP (3) JP7069177B2 (enExample)
KR (2) KR102644544B1 (enExample)
CN (1) CN110035769A (enExample)
AU (3) AU2017330346C1 (enExample)
BR (1) BR112019005292A2 (enExample)
CA (1) CA3033571A1 (enExample)
DK (1) DK3515478T3 (enExample)
ES (1) ES2982558T3 (enExample)
RU (1) RU2759334C2 (enExample)
WO (1) WO2018057735A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102644544B1 (ko) 2016-09-21 2024-03-11 넥스트큐어 인코포레이티드 Siglec-15를 위한 항체 및 이의 사용 방법
CN110386982A (zh) * 2019-04-09 2019-10-29 广东三九脑科医院 鼠抗人Siglec-15蛋白单克隆抗体制备及其用途
US11104732B2 (en) * 2019-04-24 2021-08-31 Innovative Cellular Therapeutics Holdings, Ltd. Reducing immune inhibition induced by SIGLEC-15
MX2022010217A (es) * 2020-02-21 2022-09-19 Jiangsu Hengrui Pharmaceuticals Co Ltd Composicion farmaceutica que contiene anticuerpo anti-il-4r y uso de la misma.
MX2022011951A (es) * 2020-03-27 2023-03-06 Biosion Inc Anticuerpos de la lectina 15 similar a la inmunoglobulina que se une a acido sialico (siglec15) y usos de los mismos.
US20220017604A1 (en) * 2020-04-17 2022-01-20 Washington University ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES
WO2021226163A2 (en) * 2020-05-06 2021-11-11 Dragonfly Therapeutics, Inc. Antibodies targeting clec12a and use thereof
AU2021268340A1 (en) 2020-05-06 2022-12-08 Dragonfly Therapeutics, Inc. Proteins binding NKG2D, CD16 and CLEC12A
CN113817057B (zh) * 2020-06-19 2024-02-20 盛禾(中国)生物制药有限公司 一种抗siglec15抗体及其应用
EP4222173A4 (en) * 2020-09-30 2024-10-30 NA Biotech Corp ANTI-ADENOSINE RECEPTOR (A2AR) ANTIBODIES
CN114437216A (zh) * 2020-11-05 2022-05-06 上海津曼特生物科技有限公司 抗Siglec-15抗体及其在制备药物中的应用
EP4032973B1 (en) 2021-01-21 2023-07-19 Guizhou Sinorda Biotechnology CO., Ltd. Modified t cells for adoptive immunotherapy
US20240093149A1 (en) 2020-12-08 2024-03-21 Guizhou Sinorda Biotechnology CO., Ltd. Modified t cells for adoptive immunotherapy
CN114657132A (zh) * 2020-12-22 2022-06-24 未来智人再生医学研究院(广州)有限公司 一种表达Siglec-15靶向抑制因子的多能干细胞及其衍生物与应用
CN112625132B (zh) * 2021-01-15 2022-08-02 沈阳荣欣生物制药科技有限公司 纳米抗体及其编码基因、表达载体、宿主细胞和应用
IL305409A (en) * 2021-02-23 2023-10-01 Shanghai Jemincare Pharmaceuticals Co Ltd Preparation of SIGLEC-15 binding protein and its use
CN114957468A (zh) * 2021-02-25 2022-08-30 石药集团巨石生物制药有限公司 一种抗Siglec15抗体及其用途
CN112979761B (zh) * 2021-03-19 2021-12-10 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN112961214B (zh) * 2021-03-19 2022-08-02 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
WO2022198040A1 (en) * 2021-03-19 2022-09-22 Elpis Biopharmaceuticals Antibodies specific to sialic acid-binding ig-like lectin 15 and uses thereof
CN114591434B (zh) * 2021-04-30 2023-02-28 杭州邦顺制药有限公司 抗Siglec15抗体及其制备方法和用途
WO2022237819A1 (zh) * 2021-05-13 2022-11-17 信达生物制药(苏州)有限公司 抗Siglec-15抗体及其用途
CN115701436A (zh) * 2021-08-02 2023-02-10 福州拓新天成生物科技有限公司 靶向siglec-15的嵌合抗原受体及其应用
CN118043351A (zh) * 2021-08-31 2024-05-14 上海医药集团股份有限公司 靶向Siglec15的抗原结合蛋白及其用途
CN118159286A (zh) 2021-11-25 2024-06-07 正大天晴药业集团股份有限公司 抗Siglec-15抗体及其应用
IL314839A (en) * 2022-02-22 2024-10-01 Nextpoint Therapeutics Inc KIR3DL3 inhibitors and immune cell activating agents
CN114807052A (zh) * 2022-06-07 2022-07-29 江苏亲科生物研究中心有限公司 Siglec15单克隆抗体及其制备方法和用途
CN119403838A (zh) * 2022-06-13 2025-02-07 上海生物制品研究所有限责任公司 抗siglec15抗体及其用途
CN117447592B (zh) * 2022-07-26 2024-05-28 北京东方百泰生物科技股份有限公司 一种抗Siglec-15单克隆抗体、其抗原结合片段及其应用
WO2024022008A1 (zh) * 2022-07-26 2024-02-01 北京东方百泰生物科技股份有限公司 一种抗Siglec-15单克隆抗体、其抗原结合片段及其应用
WO2024040195A1 (en) 2022-08-17 2024-02-22 Capstan Therapeutics, Inc. Conditioning for in vivo immune cell engineering
WO2024238652A2 (en) * 2023-05-15 2024-11-21 The University Of North Carolina At Chapel Hill Bispecific antibodies for cancer therapy
US20240400678A1 (en) * 2023-05-22 2024-12-05 Nextcure, Inc. Antibodies for siglec-15 and methods of use thereof to treat disuse osteoporosis
WO2024262583A1 (ja) * 2023-06-21 2024-12-26 オプティアム・バイオテクノロジーズ株式会社 Ｓｉｇｌｅｃ１５抗体およびその用途
CN117430707B (zh) * 2023-10-25 2024-04-19 重庆天科雅生物科技有限公司 一种cik细胞的制备方法及其在治疗癌症中的用途
CN117645665B (zh) * 2024-01-29 2024-05-07 北京热景生物技术股份有限公司 一种针对α-突触核蛋白的抗体及其制备方法和应用
US20250361297A1 (en) * 2024-03-12 2025-11-27 Adaptam Therapeutics, S.L. Anti- siglec-15 binding molecules and methods of use
KR20260108528A (ko) * 2024-12-31 2026-07-08 국민대학교산학협력단 Siglec-15 특이적 항체 및 이의 용도

Family Cites Families (278)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4012112A (en) 1975-08-25 1977-03-15 Honeywell Inc. Microscope stage positioning system
US4063083A (en) 1976-04-21 1977-12-13 Wade Thomas Cathey Data communication system using light coupled interfaces
US4444887A (en) 1979-12-10 1984-04-24 Sloan-Kettering Institute Process for making human antibody producing B-lymphocytes
US4716111A (en) 1982-08-11 1987-12-29 Trustees Of Boston University Process for producing human antibodies
US4741900A (en) 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
EP0149483A3 (en) 1984-01-16 1987-05-27 DeSOTO, INC. Coatings for magnetic recording structures
US4528364A (en) 1984-04-19 1985-07-09 The Dow Chemical Company Removal of alkaline catalysts from polyether polyols and polyalkylene carbonate polyols
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
AU607686B2 (en) 1985-11-25 1991-03-14 General Electric Company Crosslinkable polycyclic polycarbonate oligomers and methods for their preparation and use
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH0730154B2 (ja) 1986-04-08 1995-04-05 武田薬品工業株式会社 一液性熱硬化型樹脂組成物
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・２・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
JP2668534B2 (ja) 1987-10-06 1997-10-27 日本ポリウレタン工業 株式会社 押出成形、射出成形用熱可塑性ポリウレタン樹脂組成物
JP3095168B2 (ja) 1988-02-05 2000-10-03 エル． モリソン，シェリー ドメイン‐変性不変部を有する抗体
US5190929A (en) 1988-05-25 1993-03-02 Research Corporation Technologies, Inc. Cyclophosphamide analogs useful as anti-tumor agents
US20040049014A1 (en) 1988-12-28 2004-03-11 Protein Design Labs, Inc. Humanized immunoglobulins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5413923A (en) 1989-07-25 1995-05-09 Cell Genesys, Inc. Homologous recombination for universal donor cells and chimeric mammalian hosts
JPH03152181A (ja) 1989-11-09 1991-06-28 Teijin Chem Ltd 防曇性組成物
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
US5120727A (en) 1991-05-29 1992-06-09 American Home Products Corporation Rapamycin dimers
EP0590058B1 (en) 1991-06-14 2003-11-26 Genentech, Inc. HUMANIZED Heregulin ANTIBODy
US5202332A (en) 1991-08-07 1993-04-13 American Home Products Corporation Rapamycin analog as immunosuppressant
US5162333A (en) 1991-09-11 1992-11-10 American Home Products Corporation Aminodiesters of rapamycin
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
WO1993011794A1 (en) 1991-12-13 1993-06-24 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
GB9203459D0 (en) 1992-02-19 1992-04-08 Scotgen Ltd Antibodies with germ-line variable regions
US5714350A (en) 1992-03-09 1998-02-03 Protein Design Labs, Inc. Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
EP0633783B1 (en) 1992-03-30 2000-06-07 American Home Products Corporation Rapamycin formulation for iv injection
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
US6005079A (en) 1992-08-21 1999-12-21 Vrije Universiteit Brussels Immunoglobulins devoid of light chains
US5639641A (en) 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
CH686365A5 (de) 1992-10-06 1996-03-15 Werner Hofliger Mobilkran.
US5434260A (en) 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
ATE139900T1 (de) * 1992-11-13 1996-07-15 Idec Pharma Corp Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma
US5441050A (en) 1992-12-18 1995-08-15 Neoprobe Corporation Radiation responsive surgical instrument
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
US5387680A (en) 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
AU689153B2 (en) 1993-11-08 1998-03-26 Cressy, Wayne Malcolm Head restraining device
US5385908A (en) 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
BR9408323A (pt) 1993-12-17 1997-08-19 Sandoz Ag Derivados de rapamicina
JPH0880672A (ja) 1994-07-15 1996-03-26 Honshu Paper Co Ltd 感熱記録体
JPH08194162A (ja) 1995-01-17 1996-07-30 Nikon Corp ステージの駆動装置
CA2219361C (en) 1995-04-27 2012-02-28 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5659421A (en) 1995-07-05 1997-08-19 Neuromedical Systems, Inc. Slide positioning and holding device
CA2188503A1 (en) 1995-12-22 1997-06-23 Neil H. Nodelman Polyurethane resin transfer molding systems
US5780462A (en) 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
DE19619237A1 (de) 1996-05-13 1997-11-20 Bayer Ag Hydroxyfunktionelle Polyurethancarbonate, ein Verfahren zu deren Herstellung und deren Verwendung
US5856372A (en) 1996-05-23 1999-01-05 Arco Chemical Technology, L.P. Microcellular elastomers with improved processability and properties
US5779203A (en) 1996-06-28 1998-07-14 Edlinger; Erich Adjustable wafer cassette stand
JPH1036474A (ja) 1996-07-17 1998-02-10 Sanyo Chem Ind Ltd 膜モジュールのシール材用ポリウレタン樹脂形成性組成物
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
WO1998023289A1 (en) 1996-11-27 1998-06-04 The General Hospital Corporation MODULATION OF IgG BINDING TO FcRn
EP1972194A1 (en) 1996-12-03 2008-09-24 Amgen Fremont Inc. Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom
US6277375B1 (en) 1997-03-03 2001-08-21 Board Of Regents, The University Of Texas System Immunoglobulin-like domains with increased half-lives
US7411051B2 (en) 1997-03-07 2008-08-12 Human Genome Sciences, Inc. Antibodies to HDPPA04 polypeptide
US5989591A (en) 1997-03-14 1999-11-23 American Home Products Corporation Rapamycin formulations for oral administration
JP3876002B2 (ja) 1997-04-14 2007-01-31 ミクロメート・アクチエンゲゼルシャフト 抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
EP0896013A1 (en) 1997-08-06 1999-02-10 Shimadzu Corporation Crosslinked polycarbonate and polylactic acid composition containing the same
US5936047A (en) 1997-08-18 1999-08-10 General Electric Company Molecular weight control
US5843597A (en) 1997-12-01 1998-12-01 Eveready Battery Company, Inc. Ribbed gasket for miniature galvanic cell
US6982323B1 (en) 1997-12-23 2006-01-03 Alexion Pharmaceuticals, Inc. Chimeric proteins for diagnosis and treatment of diabetes
US6194551B1 (en) 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
CA2323757C (en) 1998-04-02 2011-08-02 Genentech, Inc. Antibody variants and fragments thereof
GB9809951D0 (en) 1998-05-08 1998-07-08 Univ Cambridge Tech Binding molecules
GB9814640D0 (en) 1998-07-06 1998-09-02 Fujisawa Pharmaceutical Co New use
US6015809A (en) 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
US6311415B1 (en) 1998-09-14 2001-11-06 Lind Shoe Company Bowling shoe with replaceable tip
HUP0104865A3 (en) 1999-01-15 2004-07-28 Genentech Inc Polypeptide variants with altered effector function
US6046301A (en) 1999-04-12 2000-04-04 Bayer Corporation Polycarbonate compositions having reduced tendency to splay
US6395554B1 (en) 1999-09-03 2002-05-28 Packard Instrument Company Microarray loading/unloading system
JP3524509B2 (ja) 2000-04-27 2004-05-10 三洋化成工業株式会社 注型用ポリウレタン樹脂形成性組成物
CN1349096A (zh) 2000-10-13 2002-05-15 聿新科技股份有限公司 电化学电极试片及其制造方法
DE10061067C1 (de) 2000-12-08 2002-06-06 Bayer Ag Kontinuierliches Verfahren zur Herstellung von thermoplastisch verarbeitbaren Polyurethanelastomeren mit definiertem und standardisiertem Schmelze-Fließ-Verhalten und hoher Thermostabilität
AUPR376101A0 (en) 2001-03-15 2001-04-12 Vision Biosystems Limited Slide holder for an automated slide loader
JP4759154B2 (ja) 2001-03-22 2011-08-31 帝人株式会社 ポリカーボネート組成物およびその製造方法
DE10138216A1 (de) 2001-08-03 2003-02-20 Bayer Ag Aliphatische Polycarbonathomo- und -copolymere durch DMC-Katalyse
US7140655B2 (en) 2001-09-04 2006-11-28 Multimetrixs Llc Precision soft-touch gripping mechanism for flat objects
JP2003147070A (ja) 2001-11-12 2003-05-21 Shigeru Tasaka 機能性オリゴマーおよびその製造方法
JP2003147185A (ja) 2001-11-15 2003-05-21 Teijin Ltd 芳香族ポリカーボネート組成物、成形物および成形方法
US7390885B2 (en) * 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
JP2003183405A (ja) 2001-12-14 2003-07-03 Teijin Ltd 粉体ポリカーボネートおよびポリカーボネート粉体組成物
US7820186B2 (en) 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
JP2003192761A (ja) 2001-12-27 2003-07-09 Mitsubishi Chemicals Corp アクリル変性ウレタン樹脂組成物及びその製造方法
US7098274B2 (en) 2002-08-27 2006-08-29 Acushnet Company Compositions for golf equipment
JP3985264B2 (ja) 2002-02-22 2007-10-03 日本ポリウレタン工業株式会社 高官能ポリカーボネートポリオールの製造方法
US7271006B2 (en) 2002-04-26 2007-09-18 Ventana Medical Systems, Inc. Method and apparatus for automated coverslipping
IL149820A0 (en) 2002-05-23 2002-11-10 Curetech Ltd Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
DE60334303D1 (de) 2002-07-03 2010-11-04 Tasuku Honjo Immunpotenzierende zusammensetzungen
JP3741085B2 (ja) 2002-07-03 2006-02-01 日立化成工業株式会社 光硬化性樹脂組成物
US7052694B2 (en) 2002-07-16 2006-05-30 Mayo Foundation For Medical Education And Research Dendritic cell potentiation
FR2844455B1 (fr) 2002-09-13 2007-12-14 Lab Francais Du Fractionnement Traitement des pathologies echappant a la reponse immune par des anticorps optimises
FR2844513B1 (fr) 2002-09-13 2007-08-03 Lab Francais Du Fractionnement Anticorps pour adcc et induisant la production de cytokines.
CA2832136C (en) 2002-09-27 2015-11-17 Xencor Optimized fc variants and methods for their generation
ES2367430T3 (es) 2002-12-23 2011-11-03 Wyeth Llc Anticuerpos contra pd-1 y sus usos.
US7960512B2 (en) 2003-01-09 2011-06-14 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US7355008B2 (en) 2003-01-09 2008-04-08 Macrogenics, Inc. Identification and engineering of antibodies with variant Fc regions and methods of using same
US7241504B2 (en) 2003-01-17 2007-07-10 The United States Of America As Represented By The Secretary Of The Navy Diols formed by ring-opening of epoxies
US7563869B2 (en) 2003-01-23 2009-07-21 Ono Pharmaceutical Co., Ltd. Substance specific to human PD-1
US7534423B2 (en) 2003-03-28 2009-05-19 Faron Pharmaceuticals Oy Method for inducing an elevated level of adenosine in an individual
SG139733A1 (en) 2003-04-11 2008-02-29 Nikon Corp Apparatus having an immersion fluid system configured to maintain immersion fluid in a gap adjacent an optical assembly
JP4413226B2 (ja) 2003-09-12 2010-02-10 ビーエーエスエフ ソシエタス・ヨーロピア 高分岐型または超分岐型の高官能性ポリカルボナート、その製造方法および使用方法
DE102004005652A1 (de) 2004-02-04 2005-08-25 Basf Ag Fließfähige Polyesterformmassen
DE102004010138B4 (de) 2004-02-27 2006-04-06 Heraeus Kulzer Gmbh Verstärkte, pressbare Keramikzusammensetzungen für Dentalzwecke
US8111373B2 (en) 2004-03-25 2012-02-07 Nikon Corporation Exposure apparatus and device fabrication method
US20090169855A1 (en) 2004-04-05 2009-07-02 George Tunis Armor Panel System
DE102004026904A1 (de) 2004-06-01 2005-12-22 Basf Ag Hochfunktionelle, hoch- oder hyperverzweigte Polyester sowie deren Herstellung und Verwendung
RU2297430C2 (ru) 2004-06-24 2007-04-20 Асахи Касеи Кемикалз Корпорейшн Композиция поликарбонатной смолы для применения в производстве субстрата для носителя оптической информации
ATE460458T1 (de) 2004-06-24 2010-03-15 Bayer Materialscience Ag Thermostabilisierte polycarbonat- zusammensetzungen
US20060099203A1 (en) 2004-11-05 2006-05-11 Pease Larry R B7-DC binding antibody
DE502005009267D1 (de) 2004-07-01 2010-05-06 Bayer Materialscience Ag Inhibierung von katalytisch aktiven Verunreinigungen in Polycarbonat nach dem Schmelzeumesterungsverfahren
MY139705A (en) 2004-07-19 2009-10-30 Basf Ag Mixtures of hyperbranched polyesters with polycarbonates as additive for polyester molding compositions
DE102004035357A1 (de) 2004-07-21 2006-03-16 Basf Ag Kontinuierliches Verfahren zur Herstellung von Polyalkylenarylaten mit hyperverzweigten Polyestern und/oder Polycarbonaten
DE102004038979A1 (de) 2004-08-10 2006-02-23 Basf Ag Schlagzähmodifizierte Polyester mit hyperverzweigten Polyestern
DE102004038976A1 (de) 2004-08-10 2006-02-23 Basf Ag Fließfähige Polyesterformmassen mit ASA/ABS und SAN
DE102004059243A1 (de) 2004-08-10 2006-02-23 Basf Ag Thermoplastische Formmassen mit verbesserten Fließ- und Entformungseigenschaften
FR2874217B1 (fr) 2004-08-10 2006-10-27 Agronomique Inst Nat Rech Polycarbonate de glycerol - compositions organiques le contenant - procede d'obtention de ces compositions organiques et procede d'extraction du polycarbonate de glycerol et leurs applications
DE102004049342A1 (de) 2004-10-08 2006-04-13 Basf Ag Fließfähige Thermoplaste mit halogenfreiem Flammschutz
DE102004050025A1 (de) 2004-10-13 2006-04-20 Basf Ag Fließfähige Thermoplaste mit Halogenflammschutz
DE102004051214A1 (de) 2004-10-20 2006-05-04 Basf Ag Fließfähige Polyoxymethylene
DE102004051241A1 (de) 2004-10-20 2006-05-04 Basf Ag Fließfähige Polyamide mit hyperverzweigten Polyestern/Polycarbonaten
US7140738B2 (en) 2004-11-24 2006-11-28 Cytyc Corporation System and method for calibrating position of microscope slide within storage receptacle
JP2006150500A (ja) 2004-11-29 2006-06-15 Elpida Memory Inc レジンボンド砥石およびそれを用いた半導体チップの製造方法
JP2006160871A (ja) 2004-12-07 2006-06-22 Seikoh Chem Co Ltd 衣料用樹脂組成物
FR2880025B1 (fr) 2004-12-23 2007-03-30 Agronomique Inst Nat Rech Polyesters de polycarbonate de glycerol et d'autres polymeres et copolymeres polyhydroxyles, procede d'acylation et applications
DE102005002119A1 (de) 2005-01-14 2006-07-27 Basf Ag Fließfähige Polyolefine
US7300163B2 (en) 2005-01-21 2007-11-27 Cytyc Corporation Slide misload detection system and method
DE102005004856A1 (de) 2005-02-01 2006-08-03 Basf Ag Fliessfähige Polyester mit Carbodilmid-Stabilisatoren
DE102005009166A1 (de) 2005-02-25 2006-08-31 Basf Ag Hochfunktionelle, hoch- oder hyperverzweigte Polycarbonate sowie deren Herstellung und Verwendung
US7374391B2 (en) 2005-12-22 2008-05-20 Applied Materials, Inc. Substrate gripper for a substrate handling robot
EP3530736A3 (en) 2005-05-09 2019-11-06 ONO Pharmaceutical Co., Ltd. Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
DE102005027549A1 (de) 2005-06-14 2006-12-21 Basf Ag Mehrkomponentenformkörper mit Polyesterschichten
KR101704734B1 (ko) 2005-07-01 2017-02-09 이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. 예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
DE102005032585A1 (de) 2005-07-11 2007-01-25 Basf Ag Verfahren zur Herstellung von Leder
EP1743897A1 (en) 2005-07-15 2007-01-17 Gesellschaft für Biotechnologische Forschung mbH Biologically active compounds obtainable from Sorangium cellulosum
DE102005034999A1 (de) 2005-07-22 2007-01-25 Basf Ag Fließfähige Polyester mit Polyesterelastomeren
DE102005034980A1 (de) 2005-07-22 2007-01-25 Basf Ag Fasern und Flüssigkeitsbehälter aus PET
US20070098997A1 (en) 2005-11-02 2007-05-03 Bayer Materialscience Llc Composite articles and a process for their production
WO2007056539A2 (en) 2005-11-08 2007-05-18 Medarex, Inc. Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
WO2007065167A1 (en) 2005-12-02 2007-06-07 The Johns Hopkins University Use of high-dose oxazaphosphorine drugs for treating immune disorders
US9155479B2 (en) 2005-12-12 2015-10-13 Tor Peters Intra cardiac device, system and methods
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
JP5173838B2 (ja) 2006-02-13 2013-04-03 アレシア・バイオセラピューティクス・インコーポレーテッド 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列
FR2901164B1 (fr) 2006-05-16 2008-08-15 Aro Soc Par Actions Simplifiee Pince a enserrer des toles, utilisee en association avec un bras manipulateur, et a module d'equilibrage deporte
US7880155B2 (en) 2006-06-15 2011-02-01 Brooks Automation, Inc. Substrate alignment apparatus comprising a controller to measure alignment during transport
US7999940B2 (en) 2006-06-30 2011-08-16 Asml Netherlands B.V. Apparatus for angular-resolved spectroscopic lithography characterization
ATE528332T1 (de) 2006-07-12 2011-10-15 Mitsubishi Chem Corp Verfahren zur herstellung von polyurethan und verwendung von danach hergestelltem polyurethan
US20090209701A1 (en) 2006-07-20 2009-08-20 Basf Se, Water-based lacquers comprising highly functional, highly branched or hyperbranched polycarbonates
JP2010500616A (ja) 2006-08-04 2010-01-07 イコニシス インコーポレーテッド 自動式顕微鏡のための自動的なカセットおよびスライド操作システム
KR20090074156A (ko) 2006-08-04 2009-07-06 아이코니시스 인코포레이티드 Ｚ-동작 현미경 슬라이드 마운트
GB2441594B (en) 2006-09-08 2011-09-07 Thermo Shandon Ltd Hopper for storing coverslips
ES2337954T3 (es) 2006-10-12 2010-04-30 Basf Se Masas moldeables de poliester termoconductivas.
TW200819421A (en) 2006-10-31 2008-05-01 Univ Nat Chunghsing The method of synthesizing biphenol A, BPA having di-alkoxyl group by using polycarbonate or its waste
BRPI0720406B1 (pt) 2006-12-19 2018-10-16 Basf Se composição de moldagem termoplástica, e, uso da mesma
CN104086735A (zh) 2006-12-20 2014-10-08 巴斯夫欧洲公司 各向异性多孔弹性体
KR100800713B1 (ko) 2007-01-29 2008-02-01 삼성전자주식회사 휴대용 단말기
JP5512283B2 (ja) 2007-01-30 2014-06-04 ビーエーエスエフ ソシエタス・ヨーロピア ポリエーテルカーボネートポリオールの製造方法
CA2678180A1 (en) 2007-02-13 2008-12-04 Northeastern University Methods and compositions for improving immune responses
JP4449998B2 (ja) 2007-03-12 2010-04-14 ヤマハ株式会社 アレイスピーカ装置
US8098956B2 (en) 2007-03-23 2012-01-17 Vantana Medical Systems, Inc. Digital microscope slide scanning system and methods
JP2008311985A (ja) 2007-06-15 2008-12-25 Panasonic Corp 位相調整装置およびデジタルカメラ
DE102007031053A1 (de) 2007-07-04 2009-01-15 Texas Instruments Deutschland Gmbh Integriertes elektronisches Gerät, einschließlich einer Schaltung zur Bereitstellung einer Systemversorgungsspannung von einer Hauptspannungsquelle
DE102007032343A1 (de) 2007-07-11 2009-01-15 Bayer Materialscience Ag Polyurethan- und Polyurethanharnstoffelastomere auf Basis von Polycarbonatpolyolen
US20090028857A1 (en) 2007-07-23 2009-01-29 Cell Genesys, Inc. Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof
WO2009021967A1 (de) 2007-08-15 2009-02-19 Basf Se POLYESTERMISCHUNG MIT VERBESSERTER FLIEßFÄHIGKEIT UND GUTEN MECHANISCHEN EIGENSCHAFTEN
US7972822B2 (en) 2007-08-17 2011-07-05 Polytechnic Institute Of New York University Enzyme-catalyzed polycarbonate and polycarbonate ester synthesis
US20090057137A1 (en) 2007-08-31 2009-03-05 Midwest Research Institute Synthesizing thin films of lithiated transition metal oxide for use in electrochemical and battery devices
JP4436393B2 (ja) 2007-09-11 2010-03-24 本田技研工業株式会社 ワイパー装置
EP2197941B1 (de) 2007-10-09 2011-05-25 Basf Se Verwendung hochfunktioneller, hochverzweigter polyetheraminpolyole zur beschichtung von oberflächen
CN108130327A (zh) 2007-10-11 2018-06-08 第三共株式会社 靶向破骨细胞相关蛋白Siglec-15的抗体
JP2011503336A (ja) 2007-11-19 2011-01-27 ビーエーエスエフ ソシエタス・ヨーロピア 凍結／融解安定性が向上したポリマー分散液を製造するための高分岐ポリマーの使用
NO2225337T3 (enExample) 2007-11-19 2018-01-20
BRPI0819272A2 (pt) 2007-11-20 2015-05-19 Basf Se Uso de composições de moldagem termoplásticas.
US8446125B2 (en) 2008-06-20 2013-05-21 Superior Communications, Inc. Vehicle power charger
JP2010013523A (ja) 2008-07-02 2010-01-21 Soft99 Corporation 透明樹脂部材の透明性回復方法および透明性回復用コーティング組成物
US7956285B2 (en) 2008-07-03 2011-06-07 Cooper Technologies Company Floor stand for mounting an electrical box
EA201500417A1 (ru) 2008-08-25 2015-11-30 Эмплиммьюн, Инк. Композиции антагонистов pd-1 и способы применения
KR102089887B1 (ko) 2008-09-08 2020-03-16 사우디 아람코 테크놀로지스 컴퍼니 폴리카보네이트 폴리올 조성물
CN102281998B (zh) 2009-01-14 2015-03-11 拜尔材料科学有限公司 具有低橘皮现象的长纤维热固性复合物
US20100222524A1 (en) 2009-02-27 2010-09-02 Bayer Materialscience Llc High modulus transparent thermoplastic polyurethanes characterized by high heat and chemical resistance
EP2377932B1 (en) 2009-04-09 2020-11-18 Daiichi Sankyo Company, Limited ANTI-Siglec-15 ANTIBODY
ATE517149T1 (de) 2009-05-11 2011-08-15 Basf Se Verstärkte styrolcopolymere
CN101633731B (zh) 2009-08-14 2011-08-03 广州市达志化工科技有限公司 一种脂肪族聚碳酸酯多元醇的制备方法
US20120201982A1 (en) 2009-08-18 2012-08-09 Bayer Materialscience Llc Coating compositions for glass substrates
EP2473523A2 (en) 2009-08-31 2012-07-11 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection
EP2299281B1 (en) 2009-09-16 2023-02-15 Sysmex Corporation Rack collecting unit and sample processing apparatus
CZ2009620A3 (cs) 2009-09-22 2011-04-06 Ústav makromolekulární chemie AV CR, v.v.i. Surovina pro výrobu polyurethanu a zpusob její výroby z odpadního polyurethanu
EP2507282B1 (en) 2009-12-01 2013-07-17 E.I. Du Pont De Nemours And Company Two-component polyurethane coating compositions
SG182437A1 (en) 2010-01-20 2012-08-30 Bayer Ip Gmbh Method for activating double metal cyanide catalysts for producing polyether carbonate polyols
CN101775129B (zh) 2010-02-04 2012-06-27 东南大学 一种制备聚醚碳酸酯多元醇的方法
US8530567B2 (en) 2010-02-18 2013-09-10 Basf Se Polymer dispersion which comprises a highly branched polycarbonate having unsaturated fatty acid groups
EP2796467B1 (en) * 2010-03-31 2018-03-28 Boehringer Ingelheim International GmbH Anti-CD40 antibodies
JP2011221188A (ja) 2010-04-07 2011-11-04 Sony Corp ステージ制御装置、ステージ制御方法及び顕微鏡
EP2558513A1 (en) 2010-04-14 2013-02-20 Dow Global Technologies LLC Polycarbonate polyols and polyurethanes made therefrom
US20110274932A1 (en) 2010-05-05 2011-11-10 Basf Se Component comprising an insert part and plastics jacketing, and process for production of the component
JP2012013952A (ja) 2010-06-30 2012-01-19 Sony Corp ステージ装置及び顕微鏡
CA2813314A1 (en) 2010-10-05 2012-04-12 Daiichi Sankyo Company, Limited Antibody targeting osteoclast-related protein siglec-15
US20120085961A1 (en) 2010-10-12 2012-04-12 Bayer Materialscience Llc Method for improving sound damping performance for automotive interior applications
CN105859889B (zh) * 2010-11-17 2020-01-07 中外制药株式会社 具有代替凝血因子viii的功能的功能的多特异性抗原结合分子
JP6134882B2 (ja) 2010-11-23 2017-05-31 ノボマー， インコーポレイテッド ポリカーボネートポリオール組成物
DE102010061167B3 (de) 2010-12-10 2012-05-31 Leica Microsystems Cms Gmbh Mikroskoptisch
WO2012085132A1 (en) 2010-12-22 2012-06-28 Orega Biotech Antibodies against human cd39 and use thereof
CN102206333B (zh) 2011-04-18 2013-12-04 中科院广州化学有限公司 一种低分子量聚碳酸酯多元醇及其制备方法和用途
CA2833636A1 (en) 2011-04-20 2012-10-26 Amplimmune, Inc. Antibodies and other molecules that bind b7-h1 and pd-1
CZ303628B6 (cs) 2011-06-06 2013-01-16 Ústav makromolekulární chemie AV CR, v.v.i. Smes polyolu a zpusob její prípravy
CN102382441A (zh) 2011-06-17 2012-03-21 珠海市远康企业有限公司 光学高透聚碳酸酯材料及其制备方法
EP2548907A1 (de) 2011-07-18 2013-01-23 Bayer MaterialScience AG Verfahren zur Herstellung von Polyetherpolyolen
EP2548906A1 (de) 2011-07-18 2013-01-23 Bayer MaterialScience AG Verfahren zur Aktivierung von Doppelmetallcyanidkatalysatoren zur Herstellung von Polyetherpolyolen
US8790651B2 (en) * 2011-07-21 2014-07-29 Zoetis Llc Interleukin-31 monoclonal antibody
EP2753356B1 (en) 2011-09-09 2021-12-22 Medimmune Limited Anti-siglec-15 antibodies and uses thereof
JPWO2013147212A1 (ja) 2012-03-30 2015-12-14 第一三共株式会社 新規抗Ｓｉｇｌｅｃ−１５抗体
JP5911365B2 (ja) 2012-04-20 2016-04-27 オリンパス株式会社 複合型顕微鏡
US20150138632A1 (en) 2012-05-18 2015-05-21 Huron Technologies International Inc. Slide tray and receptor for microscopic slides and method of operation
AU2013293062A1 (en) * 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
CN102911636B (zh) 2012-09-26 2013-12-18 贵阳时代沃顿科技有限公司 一种双组分聚氨酯胶粘剂及其制备方法和应用
EP3584267A1 (en) 2012-11-07 2019-12-25 Saudi Aramco Technologies Company High strength polyurethane foam compositions and methods
CN104769008B (zh) 2012-11-09 2018-03-23 科思创德国股份有限公司 制备聚醚碳酸酯多元醇的方法
WO2014093995A1 (en) 2012-12-14 2014-06-19 Tabor Rick L Reaction products containing hydroxyalkylterephthalates and methods of making and using same
US9001422B2 (en) 2013-02-28 2015-04-07 Ventana Medical Systems, Inc. Slide handling system and techniques
JP6316928B2 (ja) 2013-03-14 2018-04-25 ピーピージー・インダストリーズ・オハイオ・インコーポレイテッドＰＰＧ Ｉｎｄｕｓｔｒｉｅｓ Ｏｈｉｏ，Ｉｎｃ． ポリウレタンおよびそれから調製される物品およびコーティング、ならびにそれらを作製する方法。
WO2014194411A1 (en) 2013-06-07 2014-12-11 Clemex Technologies Inc. Automatic slide loading system and method
JP5835273B2 (ja) 2013-06-13 2015-12-24 コニカミノルタ株式会社 熱可塑性樹脂組成物
KR101823619B1 (ko) 2013-06-21 2018-01-30 사빅 글로벌 테크놀러지스 비.브이. 고 품질 및 우수한 가공성을 구비한 광학 특성 제품을 제조하기 위한 폴리카보네이트 조성물
EP2851384A1 (de) 2013-09-20 2015-03-25 Bayer MaterialScience AG Verzweigte Polyethercarbonatpolyole und Verfahren zu deren Herstellung
EP3077437A1 (de) 2013-11-27 2016-10-12 Covestro Deutschland AG Mischungen von polyethercarbonatpolyolen und polyetherpolyolen zur herstellung von polyurethanweichschaumstoffen
SG11201606629TA (en) 2014-02-26 2016-09-29 Covestro Deutschland Ag Method for producing polyether ester carbonate polyols
EP2915808A1 (en) 2014-03-07 2015-09-09 Construction Research & Technology GmbH 2-Hydroxyethyl 2-oxo-1,3-dioxolane-4-carboxylates, their preparation and use
CN104004179A (zh) 2014-04-19 2014-08-27 上海东大化学有限公司 废旧回收物制备聚醚多元醇、硬泡聚氨酯的方法及产物
US10273332B2 (en) 2014-05-05 2019-04-30 Resinate Materials Group, Inc. Recycle-content polyester polyols
EP3149533A4 (en) 2014-05-29 2017-06-07 Rarecyte, Inc. Apparatus for holding a substrate within a secondary device
US11422352B2 (en) 2014-05-29 2022-08-23 Rarecyte, Inc. Automated substrate loading
US10890748B2 (en) 2014-05-29 2021-01-12 Rarecyte, Inc. Automated substrate loading
US10802260B2 (en) 2014-05-29 2020-10-13 Rarecyte, Inc. Automated substrate loading
US20180003939A1 (en) 2014-05-29 2018-01-04 Rarecyte, Inc. Apparatus for holding a substrate within a secondary device
US11300769B2 (en) 2014-05-29 2022-04-12 Rarecyte, Inc. Automated substrate loading
TWI653701B (zh) 2014-06-09 2019-03-11 日商荏原製作所股份有限公司 Substrate attaching and detaching portion for substrate holder, wet substrate processing device including the substrate attaching and detaching portion, substrate processing device, and substrate transfer method
CN104163976A (zh) 2014-06-09 2014-11-26 江苏欣润塑胶有限公司 一种抗菌防霉塑胶
US20170129956A1 (en) 2014-06-18 2017-05-11 Daiichi Sankyo Company, Limited Anti-siglec-15 antibodies for use in treatment of osteogenesis imperfecta
CN104119486B (zh) 2014-06-27 2017-02-08 重庆阮氏塑业有限公司 一种聚碳酸酯复合材料及其制备方法
CA2947926C (en) 2014-06-27 2020-03-10 Ventana Medical Systems, Inc. Automated specimen processing systems and methods of detecting specimen-bearing microscope slides
US10018056B2 (en) 2014-07-02 2018-07-10 United Technologies Corporation Abrasive coating and manufacture and use methods
US10421836B2 (en) 2014-07-03 2019-09-24 Covestro Deutschland Ag Process for purifying polycarbonate polyols and purifying apparatus therefor
CA2957835C (en) 2014-08-11 2022-09-20 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane with high heat resistance
TWI683833B (zh) 2014-08-11 2020-02-01 美商盧伯利索先進材料有限公司 具高耐熱性之水分蒸氣穿透性熱塑性聚胺基甲酸酯、其製備方法及其應用
EP3183286A4 (en) 2014-08-20 2018-08-22 Resinate Materials Group, Inc. Polyester polyols from recycled polymers and waste streams
US20170335057A1 (en) 2014-10-29 2017-11-23 Resinate Materials Group, Inc. High recycle content polyester polyols from hydroxy-functional ketal acids, esters or amides
CN104356634A (zh) 2014-11-07 2015-02-18 苏州蔻美新材料有限公司 一种除臭透气医用膜及其制备方法
CN104610872A (zh) 2015-01-28 2015-05-13 芜湖县双宝建材有限公司 一种耐水耐老化水性聚氨酯涂料
WO2016153780A1 (en) 2015-03-20 2016-09-29 Resinate Materials Group, Inc. Cycloaliphatic polyester polyols from thermoplastic polyesters
CN107960081B (zh) 2015-05-21 2020-04-28 巴斯夫欧洲公司 能量可固化的超支化聚碳酸酯多元醇骨架多官能丙烯酸酯
CN107683300A (zh) 2015-05-21 2018-02-09 巴斯夫公司 超支化聚碳酸酯多元醇的制备与其用途
JP6341888B2 (ja) 2015-07-02 2018-06-13 大日精化工業株式会社 ポリヒドロキシウレタン樹脂及びその製造方法
CN105174822A (zh) 2015-08-18 2015-12-23 苏州赛斯德工程设备有限公司 一种建筑外墙自保温材料的制备方法
KR102810368B1 (ko) * 2015-11-10 2025-05-19 예일 유니버시티 자가면역 질환 및 암을 치료하기 위한 조성물 및 방법
CN106008948B (zh) 2016-06-20 2018-05-15 广州财睿投资咨询有限责任公司 一种基于生物质的聚碳酸酯多元醇和制备方法及其聚氨酯
JP7002254B2 (ja) 2016-09-13 2022-01-20 中国塗料株式会社 スラブ式軌道の補修材料、硬化体、スラブ式軌道の補修方法、スラブ式軌道および樹脂組成物
JP6944099B2 (ja) 2016-09-21 2021-10-06 株式会社山根商店 洗浄具
KR102644544B1 (ko) 2016-09-21 2024-03-11 넥스트큐어 인코포레이티드 Siglec-15를 위한 항체 및 이의 사용 방법
CN108070067A (zh) 2016-11-15 2018-05-25 中国科学院青岛生物能源与过程研究所 一种可交联型涂层用抗菌聚氨酯的制备方法
WO2018140073A1 (en) 2017-01-27 2018-08-02 Rarecyte, Inc. Automated substrate loading
US10053533B1 (en) 2017-04-13 2018-08-21 Presidium Usa, Inc. Oligomeric polyol compositions
CN110218257A (zh) 2019-06-24 2019-09-10 王跃驹 植物作为宿主在表达Antis15抗体中的应用

Also Published As

Publication number Publication date
CA3033571A1 (en) 2018-03-29
JP7720375B2 (ja) 2025-08-07
AU2017330346C1 (en) 2025-03-06
JP2022126630A (ja) 2022-08-30
KR20240035625A (ko) 2024-03-15
RU2019111722A (ru) 2020-10-22
AU2017330346B2 (en) 2024-10-24
AU2024266712A1 (en) 2024-12-12
JP7069177B2 (ja) 2022-05-17
EP3515478A4 (en) 2020-07-15
WO2018057735A1 (en) 2018-03-29
KR102644544B1 (ko) 2024-03-11
RU2759334C2 (ru) 2021-11-12
KR20190050816A (ko) 2019-05-13
JP2024020298A (ja) 2024-02-14
JP2019536470A (ja) 2019-12-19
WO2018057735A8 (en) 2018-06-07
AU2017330346A1 (en) 2019-02-21
RU2019111722A3 (enExample) 2020-12-21
AU2024266711A1 (en) 2024-12-12
JP7382444B2 (ja) 2023-11-16
EP3515478A1 (en) 2019-07-31
BR112019005292A2 (pt) 2019-09-03
US20190202912A1 (en) 2019-07-04
KR102928003B1 (ko) 2026-02-23
ES2982558T3 (es) 2024-10-16
CN110035769A (zh) 2019-07-19
EP3515478B1 (en) 2024-02-28
US11390675B2 (en) 2022-07-19

Similar Documents

Publication Publication Date Title
DK3601358T5 (da) Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf
DK3618863T3 (da) Anti-tigit-antistoffer og fremgangsmåder til anvendelse deraf
DK3353210T3 (da) Anti-TIGIT-antistoffer og fremgangsmåder til anvendelse
DK3215532T3 (da) Anti-TIM3-antistoffer og fremgangsmåder til anvendelse
DK3653221T3 (da) Anti-pvrig-antistoffer og anvendelsesfremgangsmåder
DK3525583T3 (da) Anti-c1s-antistoffer og fremgangsmåder til anvendelse deraf
DK3551660T3 (da) Anti-ctla-4-antistoffer og fremgangsmåder til anvendelse deraf
IL259747A (en) Antibodies targeting fc receptor-like 5 and methods of use
DK3310812T3 (da) Anti-HER2-antistoffer og fremgangsmåder til anvendelse
DK3356404T3 (da) Anti-pd1-antistoffer og fremgangsmåder til anvendelse
DK3230319T3 (da) Anti-PD-1-antistoffer og fremgangsmåder til anvendelse deraf
DK3436048T3 (da) Neoantigener og fremgangsmåder til anvendelse deraf
DK3303386T3 (da) Anti-Tau-antistoffer og fremgangsmåder til anvendlelse
DK3515490T3 (da) Antistoffer mod signalregulatorprotein-alpha og anvendelsesfremgangsmåder
IL251970B (en) Anti-cd79b antibodies and methods of use
DK3484916T3 (da) Antistoffer specifikke for hyperphosphoryleret tau og fremgangsmåder til anvendelse deraf
DK3148579T3 (da) Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf
DK3126394T3 (da) Anti-OX40-antistoffer og fremgangsmåder til anvendelse
DK3478723T3 (da) Pd l1 specifikke antistoffer og metoder til anvendelse heraf
DK3250610T3 (da) Fcrn-antistoffer og fremgangsmåder til anvendelse heraf
LT3303396T (lt) Antikūnai prieš ox40 ir jų panaudojimo būdai
DK3551209T3 (da) Insulin-fc-fusioner og fremgangsmåder til anvendelse
DK3292149T3 (da) Aktiverbare anti-cd71-antistoffer og fremgangsmåder til anvendelse deraf
DK3317284T3 (da) Benzoxazepin-oxazolidinonforbindelser og fremgangsmåder til anvendelse
DK3083689T3 (da) Anti-CD3-antistoffer og fremgangsmåder til anvendelse